109 related articles for article (PubMed ID: 7804511)
1. Urapidil in hypercholesterolemic hypertensive patients.
Ferrara LA; Leonetti G; Fogari R; Mazzola C; Mancini M; Zanchetti A
Blood Press Suppl; 1994; 4():39-44. PubMed ID: 7804511
[TBL] [Abstract][Full Text] [Related]
2. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
Zanchetti A
Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
Joglekar SJ; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
[TBL] [Abstract][Full Text] [Related]
4. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
Amodeo C; Barros LM; Batlouni M; Sousa JE
Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
[TBL] [Abstract][Full Text] [Related]
5. [The effect of urapidil on blood pressure, renal hemodynamics, lipid and glucose metabolism].
Sanjuliani AF; Fagundes VG; Francischetti EA
Arq Bras Cardiol; 1995 Jul; 65(1):59-63. PubMed ID: 8546598
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
8. [Antihypertensive effect and tolerance to urapidil. Comparison with nifedipine in a multicenter double-blind study].
Stumpe KO; Feldhaus P; Haerlin R
Fortschr Med; 1989 Jan; 107(1):54-7. PubMed ID: 2646188
[TBL] [Abstract][Full Text] [Related]
9. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.
Fogari R; Derosa G; Lazzari P; Zoppi A; Fogari E; Rinaldi A; Mugellini A
Am J Hypertens; 2004 Sep; 17(9):823-7. PubMed ID: 15363826
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of different antihypertensive drugs in the emergency department.
Hirschl MM; Seidler D; Müllner M; Kürkciyan I; Herkner H; Bur A; Laggner AN
J Hum Hypertens; 1996 Sep; 10 Suppl 3():S143-6. PubMed ID: 8872847
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure and serum lipids in hypertensive men and women aged 60-97 years.
Chau NP; Hansson L; Petitet A; Safar ME
Blood Press Suppl; 1995; 3():26-30. PubMed ID: 8535539
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
[TBL] [Abstract][Full Text] [Related]
13. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
Rump LC; Baranova E; Okopien B; Weisskopf M; Kandra A; Ferber P
Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pravastatin in hypertensive hypercholesterolaemic patients on antihypertensive drug therapy.
Celis H; Lijnen P; Fagard R; Staessen J; Thijs L; Amery A
J Hum Hypertens; 1994 Jul; 8(7):525-30. PubMed ID: 7932517
[TBL] [Abstract][Full Text] [Related]
15. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
16. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of urapidil in the management of essential hypertension: a comparison with captopril.
Rosenthal J; Haerlin R
J Hypertens Suppl; 1988 Dec; 6(2):S69-71. PubMed ID: 3068344
[TBL] [Abstract][Full Text] [Related]
18. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
19. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
Leonetti G;
Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
[TBL] [Abstract][Full Text] [Related]
20. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]